Supportive and palliative care for metastatic breast cancer: Resource allocations in low- and middle-income countries: A breast health global initiative 2013 consensus statement

Breast

Volumn 22, Issue 5, 2013, Pages 616-627

  Cleary, James ^a   Ddungu, Henry ^b,c   Distelhorst, Sandra R ^c   Ripamonti, Carla ^d   Rodin, Gary M ^e   Bushnaq, Mohammad A ^f   Clegg Lamptey, Joe N ^g   Connor, Stephen R ^h   Diwani, Msemo B ⁱ   Eniu, Alexandru ^j   Harford, Joe B ^k   Kumar, Suresh ^l   Rajagopal, M R ^m   Thompson, Beti ^m   Gralow, Julie R ^c,n   Anderson, Benjamin O ^c,n  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UGANDA CANCER INSTITUTE   (Uganda)

^c Fred Hutchinson Cancer Research Center   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f Jordan Palliative Care Society   (Jordan)

^g UNIVERSITY OF GHANA   (Ghana)

^h OPEN SOCIETY FOUNDATIONS   (United States)

ⁱ Dar es Salaam ^*  (Tanzania)

^j Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

^k NATIONAL CANCER INSTITUTE   (United States)

^l Medical College   (India)

^m Pallium India   (India)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Low and middle income countries; Metastatic breast cancer; Palliative care; Resource allocations; Site specific metastasis; Supportive care

Indexed keywords

MORPHINE;

ADVANCED CANCER; ANALGESIA; BONE METASTASIS; BRAIN METASTASIS; BREAST METASTASIS; CANCER PALLIATIVE THERAPY; CANCER PATIENT; COMMUNITY CARE; CONSENSUS; DIAGNOSTIC TEST; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HUMAN; INTESTINE OBSTRUCTION; LIVER METASTASIS; LOWEST INCOME COUNTRY; LUNG METASTASIS; MIDDLE INCOME COUNTRY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RESOURCE ALLOCATION; REVIEW; SKIN METASTASIS; SOCIOECONOMICS; SPIRITUAL CARE; SUPPORTIVE CARE; VOCATIONAL EDUCATION;

LOW- AND MIDDLE-INCOME COUNTRIES; METASTATIC BREAST CANCER; PALLIATIVE CARE; RESOURCE ALLOCATIONS; SITE-SPECIFIC METASTASIS; SUPPORTIVE CARE;

BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; DEVELOPING COUNTRIES; FEMALE; HEALTH PERSONNEL; HUMANS; INTESTINAL OBSTRUCTION; LIVER NEOPLASMS; LUNG NEOPLASMS; NEOPLASM METASTASIS; PAIN MANAGEMENT; PALLIATIVE CARE; PATIENT EDUCATION AS TOPIC; RESOURCE ALLOCATION; SKIN NEOPLASMS; SPIRITUALITY; TERMINAL CARE;

EID: 84884139938     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.07.052     Document Type: Review

References (146)

1. Rayson D., McIntyre P. Transitions to palliation: two solitudes or inevitable integration?. Curr Oncol Rep 2007, 9(4):285-289.
2. Ferris F.D., Bruera E., Cherny N., Cummings C., Currow D., Dudgeon D., et al. Palliative cancer care a decade later: accomplishments, the need, next steps - from the American Society of Clinical Oncology. JClin Oncol 2009, 27(18):3052-3058.
3. Hui D., De La Cruz M., Mori M., Parsons H.A., Kwon J.H., Torres-Vigil I., et al. Concepts and definitions for "supportive care", "best supportive care", "palliative care", and "hospice care" in the published literature, dictionaries, and textbooks. Support Care Cancer 2013, 21(3):659-685.
4. European Association for Palliative Care (EAPC) White paper on standards and norms for hospice and palliative care in Europe: Part 1. Eur J Pall Care 2009, 16/6:278-289.
5. WHO. Palliative care: World Health Organization. Available from: http://www.who.int/cancer/palliative/en/.
6. Cardoso F., Harbeck N., Fallowfield L., Kyriakides S., Senkus E. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012, 23(Suppl.7):vii11-vii19.
7. NCCN.National Comprehensive Cancer Network Breast Cancer 2013, Version 3. http://www.nccn.org.
8. Grunfeld E., Dhesy-Thind S., Levine M. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005, 172(10):1319-1320.
9. Munshi A., Gupta S., Anderson B., Yarnold J., Parmar V., Jalali R., et al. Guidelines for locoregional therapy in primary breast cancer in developing countries: the results of an expert panel at the 8th Annual Women's Cancer Initiative - Tata Memorial Hospital (WCI-TMH) Conference. Indian J Med Paediatr Oncol 2012, 33(2):112-122.
10. Shamieh O., Jazieh A.R. Modification and implementation of NCCN guidelines on palliative care in the Middle East and North Africa region. JNatl Compr Canc Netw 2010, 8(Suppl.3):S41-S47.
11. Miccinesi G., Crocetti E., Morino P., Fallai M., Piazza M., Cavallini V., et al. Palliative home care reduces time spent in hospital wards: a population-based study in the Tuscany region, Italy. Cancer Causes Control 2003, 14(10):971-977.
12. Gomez-Batiste X., Tuca A., Corrales E., Porta-Sales J., Amor M., Espinosa J., et al. Resource consumption and costs of palliative care services in Spain: a multicenter prospective study. JPain Symptom Manage 2006, 31(6):522-532.
13. von Gunten C.F. Evolution and effectiveness of palliative care. Am J Geriatr Psychiatry 2012, 20(4):291-297.
14. Gaertner J., Wuerstlein R., Ostgathe C., Mallmann P., Harbeck N., Voltz R. Facilitating early integration of palliative care into breast cancer therapy. Promoting disease specific guidelines. Breast Care 2011, 6(3):240-244.
15. Ripamonti C.I., Santini D., Maranzano E., Berti M., Roila F. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 2012, 23(Suppl.7):vii139-vii154.
16. McNeil C. Can guidelines be integrated into everyday practice? The NCCN in year 4. National comprehensive cancer network. JNatl Cancer Inst 1999, 91(9):753-755.
17. Gaertner J., Wuerstlein R., Klein U., Scheicht D., Frechen S., Wolf J., et al. Integrating palliative medicine into comprehensive breast cancer therapy - a pilot project. Breast Care 2011, 6(3):215-220.
18. Levy M.H., Back A., Benedetti C., Billings J.A., Block S., Boston B., et al. NCCN clinical practice guidelines in oncology: palliative care. JNatl Compr Canc Netw 2009, 7(4):436-473.
19. Cardoso F., Bese N., Distelhorst S.R., Bevilacqua J.L.B., Ginsburg O., Grunberg S.M., et al. Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013, 22:593-605.
20. Ganz P., Yip C., Gralow J., Distelhorst S.R., Albain K.S., Andersen B.L., et al. Supportive care after treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013, 22:606-615.
21. Anderson B.O., Shyyan R., Eniu A., Smith R.A., Yip C.H., Bese N.S., et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast 2006, 12(Suppl.1):S3-S15.
22. Anderson B.O., Cazap E., El Saghir N.S., Yip C.H., Khaled H.M., Otero I.V., et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011, 12(4):387-398.
23. Murray M.A., Wilson K., Kryworuchko J., Stacey D., O'Connor A. Nurses' perceptions of factors influencing patient decision support for place of care at the end of life. Am J Hosp Palliat Care 2009, 26(4):254-263.
24. Liao Z., Hao J., Guo Y., Reyes-Gibby C., Guo H. Assessment of cancer pain management knowledge in southwest China: a survey of 259 physicians from small city and county hospitals. JPalliat Med 2013 Jun, 16(6):692-695.
25. Luckett T., Davidson P.M., Boyle F., Liauw W., Agar M., Green A., et al. Australian survey of current practice and guideline use in adult cancer pain assessment and management: perspectives of oncologists. Asia Pac J Clin Oncol 2012 Dec 17, 10.1111/ajco.12040.
26. Silvoniemi M., Vasankari T., Vahlberg T., Vuorinen E., Clemens K.E., Salminen E. Physicians' self-assessment of cancer pain treatment skills-more training required. Support Care Cancer 2012, 20(11):2747-2753.
27. Jeba J., George R., Thangakunam B., Christopher D.J. Pain assessment and analgesic prescription for cancer patients in a medical ward: the influence of an educational intervention. Natl Med J India 2009, 22(4):177-180.
28. Rajagopal M. Setting up a pain management program. In: Kopf A, Patel N, editors. Guide to pain management in low-resource settings. Washington D.C: International Association for the Study of Pain (IASP). p. 317-320.
29. Gysels M., Richardson A., Higginson I.J. Communication training for health professionals who care for patients with cancer: a systematic review of training methods. Support Care Cancer 2005, 13(6):356-366.
30. Billings J.A., Ferris F.D., Macdonald N., Von Gunten C. The role of palliative care in the home in medical education: report from a national consensus conference. JPalliat Med 2001, 4(3):361-371.
31. Gysels M., Higginson I.J. Interactive technologies and videotapes for patient education in cancer care: systematic review and meta-analysis of randomised trials. Support Care Cancer 2007, 15(1):7-20.
32. Hauke D., Reiter-Theil S., Hoster E., Hiddemann W., Winkler E.C. The role of relatives in decisions concerning life-prolonging treatment in patients with end-stage malignant disorders: informants, advocates or surrogate decision-makers?. Ann Oncol 2011, 22(12):2667-2674.
33. Mahon M.M. Clinical decision making in palliative care and end of life care. Nurs Clin North Am 2010, 45(3):345-362.
34. Kreps G.L., Sivaram R. Strategic health communication across the continuum of breast cancer care in limited-resource countries. Cancer 2008, 113(8 Suppl.):2331-2337.
35. Murray M.A., Fiset V., Young S., Kryworuchko J. Where the dying live: a systematic review of determinants of place of end-of-life cancer care. Oncol Nurs Forum 2009, 36(1):69-77.
36. Gomes B., Calanzani N., Gysels M., Hall S., Higginson I.J. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care 2013, 12:7.
37. Higginson I.J., Sen-Gupta G.J. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. JPalliat Med 2000, 3(3):287-300.
38. Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006, 12(20 Pt 2):6243s-6249s.
39. Walkington L., Coleman R.E. Advances in management of bone disease in breast cancer. Bone 2011, 48(1):80-87.
40. Delea T., McKiernan J., Brandman J., Edelsberg J., Sung J., Raut M., et al. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. JSupport Oncol 2006, 4(7):341-347.
41. Bese N.S., Kiel K., El-Gueddari Bel K., Campbell O.B., Awuah B., Vikram B., et al. Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast 2006, 12(Suppl.1):S96-S102.
42. Feyer P., Sautter-Bihl M.L., Budach W., Dunst J., Haase W., Harms W., et al. DEGRO practical guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol 2010, 186(2):63-69.
43. Lutz S., Berk L., Chang E., Chow E., Hahn C., Hoskin P., et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 79(4):965-976.
44. Van Poznak C.H., Von Roenn J.H., Temin S. American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer. JOncol Pract 2011, 7(2):117-121.
45. Ripamonti C.I., Maniezzo M., Campa T., Fagnoni E., Brunelli C., Saibene G., et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 2009, 20(1):137-145.
46. Ripamonti C.I., Cislaghi E., Mariani L., Maniezzo M. Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study. Oral Oncol 2011, 47(3):185-190.
47. Mitera G., Fairchild A., DeAngelis C., Emmenegger U., Zurawel-Balaura L., Zhang L., et al. Amulticenter assessment of the adequacy of cancer paintreatment using the pain management index. JPalliat Med 2010, 13(5):589-593.
48. Souchon R., Wenz F., Sedlmayer F., Budach W., Dunst J., Feyer P., et al. DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol 2009, 185(7):417-424.
49. Aapro M.S., Coleman R.E. Bone health management in patients with breastcancer: current standards and emerging strategies. Breast 2012, 21(1):8-19.
50. Aapro M., Abrahamsson P.A., Body J.J., Coleman R.E., Colomer R., Costa L., et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008, 19(3):420-432.
51. Correa R., Ripamonti C., Gerders H. Malignant bowel obstruction. Supportive oncology 2008, 326-341. Elsevier, Philadelphia, USA. M.P. David, P. Feyer, P. Ortner, C. Zimmerman (Eds.).
52. Ripamonti C.I., Easson A.M., Gerdes H. Management of malignant bowel obstruction. Eur J Cancer 2008, 44(8):1105-1115.
53. Ripamonti C., Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer 2002, 12(2):135-143.
54. Ripamonti C., Twycross R., Baines M., Bozzetti F., Capri S., De Conno F., et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001, 9(4):223-233.
55. Feuer D.J., Broadley K.E., Shepherd J.H., Barton D.P. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol 1999, 75(3):313-322.
56. Larkin P.J., Sykes N.P., Centeno C., Ellershaw J.E., Elsner F., Eugene B., et al. The management of constipation in palliative care: clinical practice recommendations. Palliat Med 2008, 22(7):796-807.
57. Piccinni G., Angrisano A., Testini M., Merlicco D., Nacchiero M. Venting direct percutaneous jejunostomy (DPEJ) for drainage of malignant bowel obstruction in patients operated on for gastric cancer. Support Care Cancer 2005, 13(7):535-539.
58. Pothuri B., Montemarano M., Gerardi M., Shike M., Ben-Porat L., Sabbatini P., et al. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol 2005, 96(2):330-334.
59. Mariani P., Blumberg J., Landau A., Lebrun-Jezekova D., Botton E., Beatrix O., et al. Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study. JClin Oncol 2012, 30(35):4337-4343.
60. Mercadante S., Ripamonti C., Casuccio A., Zecca E., Groff L. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000, 8(3):188-191.
61. Ripamonti C., Mercadante S., Groff L., Zecca E., De Conno F., Casuccio A. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. JPain Symptom Manage 2000, 19(1):23-34.
62. Pestalozzi B.C., Zahrieh D., Price K.N., Holmberg S.B., Lindtner J., Collins J., et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 2006, 17(6):935-944.
63. Berghoff A.S., Bago-Horvath Z., Ilhan-Mutlu A., Magerle M., Dieckmann K., Marosi C., et al. Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors. Br J Cancer 2012, 107(9):1454-1458.
64. Cahill K.S., Chi J.H., Day A.L., Claus E.B. Trends in survival after surgery for breast cancer metastatic to the brain and spinal column in medicare patients: a population-based analysis. Neurosurgery 2011, 68(3):705-713. discussion 713.
65. Glantz M.J., Cole B.F., Forsyth P.A., Recht L.D., Wen P.Y., Chamberlain M.C., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 54(10):1886-1893.
66. Vecht C.J., Hovestadt A., Verbiest H.B., van Vliet J.J., van Putten W.L. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology 1994, 44(4):675-680.
67. Tsao M., Chow E., Wong R., R E., Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases (Protocol for a Cochrane Review) 2003, John Wiley & Sons, Ltd., Chichester, UK.
68. Flickinger J.C., Kondziolka D., Lunsford L.D., Coffey R.J., Goodman M.L., Shaw E.G., et al. Amulti-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994, 28(4):797-802.
69. Elias D., Di Pietroantonio D. Surgery for liver metastases from breast cancer. HPB: The Off J Int Hepato Pancreato Biliary Assoc 2006, 8(2):97-99.
70. Li X.P., Meng Z.Q., Guo W.J., Li J. Treatment for liver metastases from breast cancer: results and prognostic factors. World J Gastroenterol 2005, 11(24):3782-3787.
71. Cho S.W., Kitisin K., Buck D., Steel J., Brufsky A., Gillespie R., et al. Transcatheter arterial chemoembolization is a feasible palliative locoregional therapy for breast cancer liver metastases. Int J Surg Oncol 2010, 2010:251621.
72. Yhim H.Y., Han S.W., Oh D.Y., Han W., Im S.A., Kim T.Y., et al. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy. Cancer 2010, 116(12):2890-2901.
73. Ludwig C., Stoelben E., Hasse J. Disease-free survival after resection of lung metastases in patients with breast cancer. Eur J Surg Oncol 2003, 29(6):532-535.
74. Yoshimoto M., Tada K., Nishimura S., Makita M., Iwase T., Kasumi F., et al. Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat 2008, 110(3):485-491.
75. Dalal S., Palat G., Bruera E., Sweeney C., Ripamonti C. Management of dyspnea. Principles and practice of palliative care and supportive. Oncology 2006, 3rd ed. A.M. Berger, J.H. Von Roenn, J.L. Shuster (Eds.).
76. Wong C.Y., Helm M.A., Helm T.N., Zeitouni N. Patterns of skin metastases: a review of 25 years, experience at a single cancer center. Int J Dermatol 2013.
77. Kumar S., Juresic E., Barton M., Shafiq J. Management of skin toxicity during radiation therapy: a review of the evidence. JMed Imaging Radiat Oncol 2010, 54(3):264-279.
78. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., Schouten H.C., van Kleef M., Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007, 18(9):1437-1449.
79. NCCN.National Comprehensive Cancer Network Adult Pain 2012, Version 1, Available at:. http://www.nccn.org.
80. Meldrum M. The ladder and the clock: cancer pain and public policy at the end of the twentieth century. JPain Symptom Manage 2005, 29(1):41-54.
81. Powell R, Downing J, Ddungu H, Mwangi-Powel F. Pain history and pain assessment. In: Kopf A, Patel N, editors. Guide to pain management in low-resource settings. Washington D.C.: International Association for the Study of Pain (IASP). p. 67-79.
82. Hadjistavropoulos T., von Baeyer C., Craig K. Pain assessment in persons with limited ability to communicate. Handbook of pain assessment 2001, Guilford, New York, NY. 2 ed. D. Turk, R. Melzack (Eds.).
83. Kumar S.P. Utilization of brief pain inventory as an assessment tool for pain inpatients with cancer: a focused review. Indian J Palliat Care 2011, 17(2):108-115.
84. Contreras J., Valcarcel F., Domine M., Escobar Y. Sensivity to change of the Spanish validated Memorial Pain Assessment Card in cancer patients. Clin Transl Oncol 2008, 10(10):654-659.
85. Kim J.A., Choi Y.S., Lee J., Park J., Lee M.A., Yeom C.H., et al. Reliability and validity of the Korean cancer pain assessment tool (KCPAT). JKorean Med Sci 2005, 20(5):877-882.
86. Leppert W., Majkowicz M. Polish brief pain inventory for pain assessment and monitoring of pain treatment in patients with cancer. JPalliat Med 2010, 13(6):663-668.
87. Nejmi M., Wang X.S., Mendoza T.R., Gning I., Cleeland C.S. Validation andapplication of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer. JPain Symptom Manage 2010, 40(1):75-86.
88. Harding R., Selman L., Agupio G., Dinat N., Downing J., Gwyther L., et al. Validation of a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale. Health Qual Life Outcome. 2010, 8:10.
89. Chinda M., Jaturapatporn D., Kirshen A.J., Udomsubpayakul U. Reliability and validity of a Thai version of the Edmonton symptom assessment scale (ESAS-Thai). JPain Symptom Manage 2011, 42(6):954-960.
90. Zeng L., Zhang L., Culleton S., Jon F., Holden L., Kwong J., et al. Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer. JPalliat Med 2011, 14(3):337-342.
91. Rayment C., Hjermstad M.J., Aass N., Kaasa S., Caraceni A., Strasser F., et al. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European palliative care research collaborative-computerised symptom assessment study. Palliat Med November 21, 2012, 10.1177/0269216312464408.
92. Mitera G., Zeiadin N., Kirou-Mauro A., DeAngelis C., Wong J., Sanjeevan T., et al. Retrospective assessment of cancer pain management in an outpatient palliative radiotherapy clinic using the Pain Management Index. Pain Symptom Manage 2010, 39(2):259-267.
93. Haugen D.F., Hjermstad M.J., Hagen N., Caraceni A., Kaasa S. Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain 2010, 149(3):476-482.
94. Truong P.T., Abnousi F., Yong C.M., Hayashi A., Runkel J.A., Phillips T., et al. Standardized assessment of breast cancer surgical scars integrating the vancouver scar scale, short-form McGill Pain questionnaire, and patients' perspectives. Plast Reconstr Surg 2005, 116(5):1291-1299.
95. Mystakidou K., Parpa E., Tsilika E., Kalaidopoulou O., Georgaki S., Galanos A., et al. Greek McGill Pain questionnaire: validation and utility in cancer patients. JPain Symptom Manage 2002, 24(4):379-387.
96. Mystakidou K., Katsouda E., Parpa E., Tsilika E., Vlahos L. Use of the Greek McGill pain questionnaire in cancer patients. Expert Rev Pharmacoecon Outcome Res 2004, 4(2):227-233.
97. Patarica-Huber E., Boskov N., Pjevic M. Multimodal approach to therapy-related neuropathic pain in breast cancer. JBUON 2011, 16(1):40-45.
98. Mishra S., Bhatnagar S., Gupta D., Nirwani Goyal G., Jain R., Chauhan H. Management of neuropathic cancer pain following WHO analgesic ladder: a prospective study. Am J Hosp Palliat Care 2008, 25(6):447-451.
99. WHO. Pain ladder: World Health Organization. Available at: http://www.who.int/cancer/palliative/painladder/en/.
100. Jonsson T., Christrup L.L., Hojsted J., Villesen H.H., Albjerg T.H., Ravn-Nielsen L.V., et al. Symptoms and side effects in chronic non-cancer pain: patient report vs. systematic assessment. Acta Anaesthesiol Scand 2011, 55(1):69-74.
101. Mosher C.E., Duhamel K.N. An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology 2012, 21(1):100-107.
102. Lo C., Zimmermann C., Rydall A., Walsh A., Jones J.M., Moore M.J., et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. JClin Oncol 2010, 28(18):3084-3089.
103. Rodin G., Lo C., Mikulincer M., Donner A., Gagliese L., Zimmermann C. Pathways to distress: the multiple determinants of depression, hopelessness, and the desire for hastened death in metastatic cancer patients. Soc Sci Med 2009, 68(3):562-569.
104. Jafari N., Zamani A., Lazenby M., Farajzadegan Z., Emami H., Loghmani A. Translation and validation of the Persian version of the functional assessment of chronic illness therapy-Spiritual well-being scale (FACIT-Sp) amongMuslim Iranians in treatment for cancer. Palliat Supp Care 2013, 11(1):29-35.
105. Lazenby M., Khatib J., Al-Khair F., Neamat M. Psychometric properties of the functional assessment of chronic illness therapy-spiritual well-being (FACIT-Sp) in an Arabic-speaking, predominantly Muslim population. Psychooncology 2013, 22(1):220-227.
106. Ku Y.L., Kuo S.M., Yao C.Y. Establishing the validity of a spiritual distress scale for cancer patients hospitalized in southern Taiwan. Int J Palliat Nurs 2010, 16(3):134-138.
107. Yong J., Kim J., Han S.S., Puchalski C.M. Development and validation of a scale assessing spiritual needs for Korean patients with cancer. JPalliat Care 2008, 24(4):240-246.
108. Peterman A.H., Fitchett G., Brady M.J., Hernandez L., Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy-spiritual well-being scale (FACIT-Sp). Ann Behav Med 2002, 24(1):49-58.
109. Gil F., Grassi L., Travado L., Tomamichel M., Gonzalez J.R. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer 2005, 13(8):600-606.
110. Spirituality in cancer care 2012, National Cancer Institute, USA, Available at:. http://www.cancer.gov/cancertopics/pdq/supportivecare/spirituality/Patient/page1.
111. Wildes K.A., Miller A.R., de Majors S.S., Ramirez A.G. The religiosity/spirituality of Latina breast cancer survivors and influence on health-related quality of life. Psychooncology 2009, 18(8):831-840.
112. Purnell J.Q., Andersen B.L., Wilmot J.P. Religious practice and spirituality in the psychological adjustment of survivors of breast cancer. Couns Values 2009, 53(3):165.
113. Djuric Z., Mirasolo J., Kimbrough L., Brown D.R., Heilbrun L.K., Canar L., et al. Apilot trial of spirituality counseling for weight loss maintenance in African American breast cancer survivors. JNatl Med Assoc 2009, 101(6):552-564.
114. Ahmad F., Muhammad M., Abdullah A.A. Religion and spirituality in coping with advanced breast cancer: perspectives from Malaysian Muslim women. JRelig Health 2011, 50(1):36-45.
115. Harandy T.F., Ghofranipour F., Montazeri A., Anoosheh M., Bazargan M., Mohammadi E., et al. Muslim breast cancer survivor spirituality: coping strategy or health seeking behavior hindrance?. Health Care Women Int 2010, 31(1):88-98.
116. Gullatte M.M., Brawley O., Kinney A., Powe B., Mooney K. Religiosity, spirituality, and cancer fatalism beliefs on delay in breast cancer diagnosis in African American women. JRelig Health 2010, 49(1):62-72.
117. Lagman R.A., Yoo G.J., Levine E.G., Donnell K.A., Lim H.R. "Leaving it to God" religion and spirituality among Filipina immigrant breast cancer survivors. JRelig Health 2012.
118. Tate J.D. The role of spirituality in the breast cancer experiences of African American women. JHolist Nurs 2011, 29(4):249-255.
119. Baker R., Wu A.W., Teno J.M., Kreling B., Damiano A.M., Rubin H.R., et al. Family satisfaction with end-of-life care in seriously ill hospitalized adults. JJ Am Geriatr Soc 2000, 48(5 Suppl.):S61-S69.
120. Murray M.A., Stacey D., Wilson K.G., O'Connor A.M. Skills training to support patients considering place of end-of-life care: a randomized control trial. JPalliat Care 2010, 26(2):112-121.
121. Cherny N.I. Controversies in oncologist-patient communication: a nuanced approach to autonomy, culture, and paternalism. Oncology (Williston Park) 2012, 26(1):37-43. 6.
122. Cherny N.I. Factors influencing the attitudes and behaviors of oncologists regarding the truthful disclosure of information to patients with advanced and incurable cancer. Psychooncology 2011, 20(12):1269-1284.
123. Belanger E., Rodriguez C., Groleau D. Shared decision-making in palliative care: a systematic mixed studies review using narrative synthesis. Palliat Med 2011, 25(3):242-261.
124. NCCN.National Comprehensive Cancer Network Palliative Care 2012, Version 2, Available from:. http://www.nccn.org.
125. Glare P.A., Semple D., Stabler S.M., Saltz L.B. Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria. JOncol Pract 2011, 7(6):366-370.
126. Reville B., Reifsnyder J., McGuire D.B., Kaiser K., Santana A.J. Education and referral criteria: impact on oncology referrals to palliative care. JPalliat Med 2013 Jul, 16(7):786-789.
127. Currow D.C., Allingham S., Bird S., Yates P., Lewis J., Dawber J., et al. Referral patterns and proximity to palliative care inpatient services by level of socio-economic disadvantage. A national study using spatial analysis. BMC Health Serv Res 2012, 12:424.
128. Ahluwalia S.C., Fried T.R. Physician factors associated with outpatient palliative care referral. Palliat Med 2009, 23(7):608-615.
129. Akashi M., Yano E., Aruga E. Under-diagnosis of pain by primary physicians and late referral to a palliative care team. BMC Palliat Care 2012, 11:7.
130. Baek Y.J., Shin D.W., Choi J.Y., Kang J., Mo H.N., Kim Y.H., et al. Late referral to palliative care services in Korea. JPain Symptom Manage 2011, 41(4):692-699.
131. Bestall J.C., Ahmed N., Ahmedzai S.H., Payne S.A., Noble B., Clark D. Access and referral to specialist palliative care: patients' and professionals' experiences. Int J Palliat Nurs 2004, 10(8):381-389.
132. Broom A., Kirby E., Good P., Wootton J., Adams J. The art of letting go: referral to palliative care and its discontents. Soc Sci Med 2013, 78:9-16.
133. Auret K., Bulsara C., Joske D. Australasian haematologist referral patterns to palliative care: lack of consensus on when and why. Intern Med J 2003, 33(12):566-571.
134. Smith C.B., Nelson J.E., Berman A.R., Powell C.A., Fleischman J., Salazar-Schicchi J., et al. Lung cancer physicians' referral practices for palliative care consultation. Ann Oncol 2012, 23(2):382-387.
135. Broom A., Kirby E., Good P., Wootton J., Adams J. Specialists' experiences and perspectives on the timing of referral to palliative care: a qualitative study. JPalliat Med 2012, 15(11):1248-1253.
136. Rocque G.B., Barnett A.E., Illig L.C., Eickhoff J.C., Bailey H.H., Campbell T.C., et al. Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?. JOncol Pract 2013, 9(1):51-54.
137. DeVader T.E., Jeanmonod R. The effect of education in hospice and palliative care on emergency medicine residents' knowledge and referral patterns. JPalliat Med 2012, 15(5):510-515.
138. Dalal S., Palla S., Hui D., Nguyen L., Chacko R., Li Z., et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist 2011, 16(1):105-111.
139. Rhondali W., Burt S., Wittenberg-Lyles E., Bruera E., Dalal S. Medical oncologists' perception of palliative care programs and the impact of name change to supportive care on communication with patients during the referral process. A qualitative study. Palliat Support Care 2013, 1-8.
140. Wentlandt K., Krzyzanowska M.K., Swami N., Rodin G.M., Le L.W., Zimmermann C. Referral practices of oncologists to specialized palliative care. JClin Oncol 2012, 30(35):4380-4386.
141. Eniu A., Carlson R.W., El Saghir N.S., Bines J., Bese N.S., Vorobiof D., et al. Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer 2008, 113(8 Suppl.):2269-2281.
142. Lynch T., Connor S., Clark D. Mapping levels of palliative care development: a global update. JPain Symptom Manage 2013, 45(6):1094-1106.
143. Casarett D., Johnson M., Smith D., Richardson D. The optimal delivery of palliative care: a national comparison of the outcomes of consultation teams vs inpatient units. Arch Intern Med 2011, 171(7):649-655.
144. Grant L., Brown J., Leng M., Bettega N., Murray S.A. Palliative care making a difference in rural Uganda, Kenya and Malawi: three rapid evaluation field studies. BMC Palliat Care 2011, 10:8.
145. Davaasuren O., Stjernsward J., Callaway M., Tsetsegdary G., Hagan R., Govind S., et al. Mongolia: establishing a national palliative care program. JPain Symptom Manage 2007, 33(5):568-572.
146. Pastrana T., Vallath N., Mastrojohn J., Namukwaya E., Kumar S., Radbruch L., et al. Disparities in the contribution of low- and middle-income countries to palliative care research. JPain Symptom Manage 2010, 39(1):54-68.